Neuland Laboratories Limited. — Call Transcript 2022

May 5, 2022

==> picture [124 x 83] intentionally omitted <==

==> picture [108 x 67] intentionally omitted <==

Neuland Laboratories Limited’s Q4FY22 Results Conference Call At 18:00 hrs. IST on May 10, 2022

Neuland Laboratories Limited will announce its results for the fourth quarter and financial year ended March 31, 2022 on May 10, 2022. The results will also be made available on the website of the Company, www.neulandlabs.com

Following the announcement, the management of the Company will host an Earnings Call on May 10, 2022 at 18:00 hrs . The details of the earnings call are:

Date: May 10, 2022

Time: 18:00 Hrs

For Zoom Link Registration Please Click Here:

Zoom Link

About Neuland Laboratories Limited (BSE:524558, NSE: NEULANDLAB)

For over 38 years, Neuland Labs has been at the forefront of manufacturing APIs through its cGMP manufacturing facilities, working with customers in close to 80 countries. Neuland Labs has developed more than 300 processes and 100 APIs and has filed around 900 Regulatory filings in the US (62 active US DMFs), the European Union (EU) and other geographies. Its record of quality manufacturing and reliability is highlighted by cGMP certifications that include the U.S. FDA, TGA (Australia), EDQM (EU), German Health Authority, ANVISA (Brazil), EMA (EU), Cofepris (Mexico), KFDA (Korea), PMDA (Japan), CFDA (China), FSI “SID &GP” Russia, Health Canada, ISO 9001, ISO14001, OHSAS18001 and ISO 27001.

For more information, visit www.NeulandLabs.com.

For more queries please contact:

Neuland: ir@neulandlabs.com OR Diwakar Pingle: diwakar.pingle@in.ey.com